CTVA SEC Filings

Corteva, Inc. reported robust performance for the year ended December 31, 2025, with net sales increasing by 3% to $17.4 billion, driven by a 1% rise in price and a 3% increase in volume. This growth was achieved despite a 1% unfavorable currency impact. The company demonstrated strong operational execution, with Cost of Goods Sold (COGS) decreasing to $9.2 billion due to cost-saving initiatives, raw material deflation, and lower commodity prices, partially offset by higher volumes. Income from continuing operations after taxes significantly improved to $1.2 billion from $863 million in the prior year, with Operating EBITDA rising to $3.8 billion from $3.4 billion. Key strategic priorities for Corteva include delivering top-tier technology, increasing market share in seed trait out-licensing, driving operational improvements, and completing the intended separation of its Seed and Crop Protection businesses into two standalone public companies by the second half of 2026. The company also returned approximately $1.5 billion to shareholders through share repurchases and dividends in 2025, underscoring its commitment to shareholder value. Corteva remains focused on innovation and deploying capital with discipline to drive organic and inorganic growth.

Corteva, Inc. (CTVA) has filed an 8-K on February 3, 2026, to report its financial results for the quarter and full year ended December 31, 2025. While the filing itself is brief and primarily an informational update, it signifies the release of the company's detailed financial performance for the period. Investors should refer to the furnished exhibits, specifically the Press Release (Exhibit 99.1) and Financial Statement Schedules (Exhibit 99.2), for comprehensive insights into the company's revenue, profitability, and other key financial metrics for the fiscal year 2025.

Corteva, Inc. reported a net loss of $320 million, or $0.47 per share, for the third quarter of 2025, a significant improvement from the prior year's loss of $524 million, or $0.76 per share. This turn-around was driven by a substantial increase in net sales, which grew 13% to $2.62 billion, fueled by a 12% volume increase and a favorable 2% currency impact, partially offset by a 1% price decline. The company's Seed segment showed particular strength, with net sales up 33% driven by early deliveries in Brazil and recovery in Argentina, while the Crop Protection segment also saw a 4% increase in net sales due to demand for new products. For the nine-month period, net sales increased by 4% to $13.49 billion, with net income reaching $1.65 billion, a significant improvement from $958 million in the prior year. This performance reflects strategic execution in both segments, with the Seed segment benefiting from strong pricing and volume growth and the Crop Protection segment seeing benefits from raw material deflation and productivity savings. The company also announced its intent to separate into two independent publicly traded companies, one focused on seeds and the other on crop protection, a move expected to unlock further value.

Corteva, Inc. (CTVA) has filed a Form 8-K on November 3, 2025, reporting its financial results for the quarter ended September 30, 2025. The filing primarily serves to announce these results, which are detailed in an accompanying press release (Exhibit 99.1) and financial statement schedules (Exhibit 99.2). Investors should note that this information is furnished and not deemed "filed" under Section 18 of the Exchange Act, meaning it does not carry the same liability implications, nor will it be automatically incorporated into future SEC filings unless explicitly referenced. While the specifics of the financial performance are contained within the exhibits, this 8-K signals the release of key quarterly data. Investors interested in Corteva's operational performance, profitability, and financial condition for the third quarter of 2025 will need to review the furnished press release and financial statements. The filing is a standard procedural step for publicly traded companies to disseminate material financial information to the market.

Corteva, Inc. (CTVA) has announced a significant strategic move to separate into two independent, publicly traded companies via a tax-free spin-off, as detailed in their 8-K filing dated October 1, 2025. This decision marks a pivotal moment for the company, aiming to unlock greater value and strategic focus for each new entity. Investors should pay close attention to the details of this separation as it will reshape the company's structure and potentially its market position. Further details regarding the spin-off and commentary on expected 2025 financial performance will be discussed during an investor call scheduled for October 1, 2025. While the specific financial outcomes of the separation are yet to be fully disclosed, the intent to create two distinct entities suggests a move towards enhancing operational efficiency, pursuing specialized growth strategies, and providing clearer investment profiles for each business segment. Investors will be looking for information on the go-to-market strategies and financial projections for both new companies.

Corteva, Inc. announced a significant leadership transition within its legal and public affairs functions. Cornel Fuerer, Senior Vice President, Chief Legal and Public Affairs Officer, will retire from his executive officer role effective September 15, 2025. While Mr. Fuerer will transition his public affairs oversight and corporate secretary duties to his successor by the end of 2025, he will continue to serve as a strategic advisor until sometime in 2026, ensuring a smooth handover. Taking over the Chief Legal Officer role is Jennifer A. Johnson, a seasoned legal executive with extensive experience in the chemical and life sciences industries. Her background includes significant roles at International Flavors & Fragrances Inc. (IFF) and DuPont de Nemours, Inc., where she gained direct experience with Corteva's former parent company and its seed business. This appointment signals a focus on strengthening the company's legal and compliance framework.

Corteva, Inc. reported a strong second quarter and first half of 2025, with net sales increasing by 6% and 3% respectively, driven by volume growth and price increases across both its Seed and Crop Protection segments. The company demonstrated improved profitability, with net income rising significantly compared to the prior year, reflecting effective cost management and productivity initiatives. Operating EBITDA also saw substantial year-over-year growth, underscoring operational efficiencies and strong market performance, particularly in North America. Corteva continues to return value to shareholders through share repurchases and dividends, and is actively managing its operational footprint with ongoing restructuring efforts in its Crop Protection segment expected to yield significant savings. While the company experienced some unfavorable currency impacts, its diverse geographic presence and product portfolio helped mitigate these effects. Corteva remains focused on innovation and strategic investments in research and development to support its long-term growth. The company's financial position appears robust, with ample liquidity and access to credit facilities to fund its operations and strategic initiatives. Investors will be closely monitoring the progress of the Crop Protection restructuring and the ongoing legal and environmental matters, which, while managed, represent potential areas of future impact.

Corteva, Inc. (CTVA) has filed an 8-K report on August 6, 2025, to announce its financial results for the second quarter ended June 30, 2025. The filing includes a press release and financial statement schedules, furnished as exhibits. This report provides investors with an update on the company's operational and financial performance during the recently concluded quarter. Investors should refer to the furnished exhibits (99.1 and 99.2) for detailed financial information, including revenue, earnings, segment performance, and any forward-looking guidance. While this information is being furnished and not deemed "filed" for purposes of Section 18 of the Exchange Act, it is crucial for understanding Corteva's recent financial health and strategic positioning in the agricultural sector.

Corteva, Inc. reported a net income of $656 million for the first quarter of 2025, a significant increase from $423 million in the same period of the prior year. This improvement was driven by higher income from continuing operations, which rose to $667 million from $376 million. Diluted earnings per share also saw a substantial increase, reaching $0.95 compared to $0.60 year-over-year. Net sales for the quarter were $4,417 million, a slight decrease of 2% compared to $4,492 million in Q1 2024. This was primarily due to a 5% unfavorable currency impact, partially offset by a 2% increase in volume and a 1% increase in price. The company continues to navigate global economic conditions, including currency fluctuations, while focusing on operational efficiencies and strategic pricing. The company also returned approximately $385 million to shareholders through share repurchases and dividends.

Corteva, Inc. (CTVA) has filed a Current Report (8-K) on May 7, 2025, announcing its financial results for the quarter ended March 31, 2025. The filing primarily includes a press release and financial statement schedules, furnished as exhibits. Investors should note that this information is furnished and not deemed 'filed' for purposes of liability under the Securities Exchange Act of 1934, nor is it automatically incorporated into future SEC filings unless expressly referenced. The key takeaway for investors is the announcement of the company's performance in the first quarter of 2025. While the detailed financial figures are within the furnished exhibits (99.1 and 99.2), the 8-K itself signals the release of this crucial operational and financial data. Investors will need to consult the accompanying press release and financial statements for specific metrics such as revenue, earnings per share, segment performance, and any forward-looking guidance provided by the company.

Corteva, Inc. filed an 8-K on May 5, 2025, detailing the results of its Annual Meeting of Stockholders held on April 30, 2025. The meeting saw strong participation, with over 89% of outstanding shares represented. Key outcomes include the election of all 12 director nominees and an advisory vote to approve executive compensation, both of which passed with significant support from shareholders. Additionally, the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm for 2025 was ratified by stockholders. These results indicate shareholder confidence in the current board of directors and management's compensation structure. The overwhelming ratification of the independent auditor suggests satisfaction with the company's financial reporting oversight. Investors can view these outcomes as stable governance and continued trust in the company's auditing process as Corteva moves forward.

Corteva, Inc. announced a change in its Board of Directors, with Dr. Rebecca Liebert resigning from her position effective February 28, 2025. Dr. Liebert's departure is attributed to her decision to pursue other opportunities and is not due to any disagreements with the company's management or policies. This change will result in a reduction of the Board's size from thirteen to twelve directors.

Corteva, Inc. reported net sales of $16.9 billion for the year ended December 31, 2024, a 2% decrease compared to the prior year. This decline was primarily attributed to a 1% decrease in price and a 3% unfavorable currency impact, partially offset by a 2% increase in volume. The company's Seed segment saw a 1% increase in net sales, driven by price gains and volume growth in key regions like Brazil and North America. Conversely, the Crop Protection segment experienced a 5% decrease in net sales due to lower pricing and unfavorable currency impacts, despite a 3% volume increase. The company returned approximately $1.5 billion to shareholders through share repurchases and dividends in 2024. Corteva is focused on delivering innovative technology, accelerating innovation to farmers, and deploying capital with discipline. Despite a slight revenue dip, Corteva demonstrated resilience through operational execution and strategic investments, such as the acquisitions of Stoller and Symborg in the biologicals space. The company continues to manage its cost structure effectively, with COGS decreasing by $391 million year-over-year, largely due to favorable currency effects and productivity actions. Looking ahead, Corteva remains committed to its value creation framework and delivering differentiated solutions to farmers.

Corteva, Inc. (CTVA) has filed an 8-K report on February 5, 2025, to announce its financial results for the fourth quarter and full year ended December 31, 2024. The report primarily serves as a notification of the release of their earnings press release and financial statement schedules, which are furnished as exhibits. Investors should refer to these furnished documents (Exhibits 99.1 and 99.2) for detailed information regarding the company's performance, financial condition, and any forward-looking statements or strategic updates. While this 8-K itself does not contain the financial details, it directs stakeholders to the official press release and detailed schedules for a comprehensive understanding of Corteva's 2024 performance and outlook. It's important to note that the information furnished in this report is not considered "filed" for the purposes of Section 18 of the Exchange Act, meaning it does not carry the same legal liabilities as officially filed documents. Investors should consult Exhibits 99.1 and 99.2 for the substantive financial and operational information.

Corteva, Inc. reported net sales of $2,326 million for the third quarter of 2024, a decrease of 10% compared to the same period in the prior year, primarily driven by an 8% decrease in price and a 5% unfavorable currency impact, partially offset by a 3% increase in volume. The company experienced a net loss of $521 million for the quarter, compared to a net loss of $318 million in the prior year quarter. For the first nine months of 2024, net sales decreased by 4% to $12,930 million, with a net income of $948 million compared to $988 million in the same period last year. The company is navigating a competitive pricing environment in Crop Protection, particularly in Latin America, and reduced corn planted area in Argentina impacted Seed volumes. Despite these challenges, Corteva continues to invest in R&D and is implementing cost and productivity initiatives. The company also announced a restructuring program for its Crop Protection network, expected to yield significant savings by 2027. Corteva's outlook for full-year 2024 anticipates net sales between $17.0 billion and $17.2 billion, with Operating EBITDA expected to be between $3.35 billion and $3.45 billion. The company remains committed to returning capital to shareholders through dividends and share repurchases.

Corteva, Inc. (CTVA) has filed an 8-K detailing its financial results for the quarter ended September 30, 2024, and providing an update on its Crop Protection Operations Strategy Restructuring Program. While the 8-K primarily furnishes the press release regarding Q3 2024 results (Exhibit 99.1), the more significant update for investors relates to the revised restructuring plan. Corteva now anticipates aggregate pre-tax restructuring and asset-related charges between $650 million and $700 million, an increase from previous estimates. This includes substantial asset-related and impairment charges, as well as costs associated with exiting production activities, primarily at the Pittsburg, California site.

Corteva, Inc. (CTVA) announced a significant leadership transition within its Seed business unit. Timothy Glenn, Executive Vice President of the Seed business unit, has notified the company of his intent to retire effective December 1, 2024. Mr. Glenn will continue to support the company as an advisor through February 2025 to ensure a smooth handover. To succeed Mr. Glenn, Corteva has appointed Judd O’Connor as the new Executive Vice President of the Seed business unit, also effective December 1, 2024. Mr. O’Connor brings extensive experience, having served as the company's Commercial President for North America since July 2022 and holding various leadership roles within the Seed business and its predecessor entities for over 25 years. This succession plan aims to leverage Mr. O'Connor's deep industry knowledge to continue driving growth and innovation in Corteva's crucial seed segment.

Corteva, Inc. reported solid results for the second quarter of 2024, demonstrating resilience and strategic execution. Net sales increased by 1% year-over-year to $6.112 billion, driven by a 2% price increase that offset a 1% unfavorable impact from portfolio and other changes, while volumes remained flat overall. The Seed segment showed particular strength, with net sales up 2% driven by strong pricing and a favorable product mix, contributing significantly to a 16% increase in segment operating EBITDA. This segment is outperforming the market and gaining share, underscoring the value of its advanced germplasm and trait technologies. While the Crop Protection segment's net sales were flat year-over-year, driven by increased volumes in certain areas offset by price declines and currency headwinds, its segment operating EBITDA decreased by 20%. This was attributed to competitive pricing and raw material cost inflation, despite productivity savings and volume growth. The company continues to navigate a challenging market environment in Crop Protection but expects elevated input costs to subside in the second half of 2024. Overall, Corteva reiterated its full-year 2024 outlook for net sales and Operating EBITDA, signaling confidence in its strategic direction and operational capabilities.

Corteva, Inc. (CTVA) filed an 8-K on July 31, 2024, reporting its financial results for the quarter ended June 30, 2024, and announcing a significant executive leadership change. While the filing provides details on financial performance, the primary focus for investors in this report is the transition in the Chief Financial Officer role. The company is also providing information on its Q2 2024 results via press releases, which are furnished as exhibits, but the core of the 8-K relates to personnel changes. The most impactful news for investors concerns the retirement of current CFO David J. Anderson, effective September 16, 2024, after a distinguished tenure. He will transition to an advisory role until February 2025. Succeeding him will be David P. Johnson, a seasoned executive with over 30 years of financial leadership experience, most recently at Atkore Inc. This transition represents a key moment for Corteva's financial strategy and execution moving forward.

Corteva, Inc. (CTVA) filed an 8-K on May 1, 2024, reporting on its Annual Meeting of Stockholders held on April 26, 2024. The most significant event for investors is the approval and subsequent filing of an amendment to the Company's certificate of incorporation. This amendment permits the exculpation of officers, aligning with Delaware General Corporation Law, and became effective on May 1, 2024. While this primarily impacts corporate governance, it signifies management's focus on maintaining strong governance practices. The meeting also saw strong shareholder support for the election of all 13 director nominees and the ratification of PricewaterhouseCoopers LLP as the independent registered public accounting firm for 2024. Additionally, shareholders approved, by advisory vote, the compensation of the named executive officers, indicating general confidence in the company's executive compensation strategy.

Corteva, Inc. reported first quarter 2024 net sales of $4,492 million, a decrease of 8% compared to the prior year, primarily driven by a 9% decrease in volume, partially offset by a 3% increase in price. Net income attributable to Corteva was $419 million, or $0.60 per share, down from $595 million, or $0.84 per share, in the first quarter of 2023. The decline in earnings was influenced by lower sales volumes, increased R&D expenses, and higher restructuring charges related to the Crop Protection Operations Strategy Restructuring Program. The company is reaffirming its full-year 2024 outlook, expecting net sales between $17.4 billion and $17.7 billion and Operating EBITDA between $3.5 billion and $3.7 billion. Despite the year-over-year decline in the first quarter, management anticipates market growth in the second half of 2024, particularly in the Crop Protection segment, and continues to focus on cost and productivity improvements. Corteva also returned approximately $365 million to shareholders through share repurchases and dividends in the first quarter.

Corteva, Inc. (CTVA) has filed an 8-K report on May 1, 2024, to announce its consolidated financial results for the quarter ended March 31, 2024. The report primarily serves to furnish the company's press release and financial statement schedules, which contain the detailed financial performance information for the period. Investors should refer to Exhibits 99.1 and 99.2 for the specific figures and commentary regarding Corteva's operational and financial condition during the first quarter of 2024. While the 8-K itself does not contain the granular financial data, it directs stakeholders to the accompanying press release and schedules for comprehensive insights into revenue, profitability, segment performance, and any forward-looking statements or guidance provided by the company. The information is furnished, not filed, meaning it does not carry the same legal liabilities under Section 18 of the Exchange Act.

Corteva, Inc. reported net sales of $17.2 billion for the fiscal year 2023, a slight decrease of 1% compared to the previous year, primarily attributed to a 10% volume decline partially offset by a 7% price increase and a favorable portfolio impact from acquisitions. The company's operating EBITDA improved to $3.4 billion, driven by strong price execution and productivity initiatives. Corteva successfully integrated two biologicals companies, Stoller and Symborg, in early 2023, enhancing its crop protection portfolio. The company returned approximately $1.2 billion to shareholders through share repurchases and dividends in 2023, reflecting a commitment to capital deployment. Looking ahead to 2024, Corteva anticipates net sales between $17.4 billion and $17.7 billion and operating EBITDA between $3.5 billion and $3.7 billion, indicating confidence in continued growth and operational efficiency. Significant emphasis was placed on innovation and sustainability, with increased investment in R&D to deliver differentiated solutions. The company continues to manage risks associated with regulatory approvals, supply chain dynamics, and evolving market conditions, while also navigating ongoing litigation related to legacy EIDP businesses, particularly concerning PFAS matters.

Corteva, Inc. (CTVA) filed an 8-K on January 31, 2024, to report its financial results for the quarter and full year ended December 31, 2023. The filing includes a press release (Exhibit 99.1) and financial statement schedules (Exhibit 99.2), which contain the detailed financial performance information. Investors should refer to these exhibits for a comprehensive understanding of the company's operational and financial condition as of year-end 2023. While this 8-K primarily serves as a notification and furnishing of the financial results press release, it is crucial for investors to review the attached exhibits. These documents will provide insights into key performance indicators, revenue figures, profitability, and any forward-looking statements or management commentary regarding the company's outlook. The information furnished is not considered 'filed' for certain regulatory purposes, but it remains the primary source for understanding Corteva's latest financial standing.

Corteva, Inc. reported a net sales decline of 7% for the third quarter of 2023 compared to the prior year, driven primarily by a 15% decrease in volume, though partially offset by price increases and favorable currency impacts. For the first nine months of the year, net sales saw a slight decrease of 1%, also primarily due to lower volumes which were impacted by strategic product exits, inventory destocking, and delayed farmer purchases. The company has been investing in research and development, with an increase in R&D expenses year-over-year to support long-term growth. Significant progress has been made integrating the Stoller and Symborg acquisitions, which supplement the crop protection business with biological tools. Despite the sales volume challenges, Corteva's financial performance was supported by pricing strategies and cost management initiatives. The company is also actively managing its capital structure, including share repurchases and dividend payments.

Corteva, Inc. (CTVA) announced its third-quarter financial results for the period ending September 30, 2023, via an 8-K filing on November 8, 2023. While the filing primarily furnishes the earnings press release, a significant development disclosed is a plan to optimize its Crop Protection manufacturing network. This plan includes the closure of its Pittsburg, California site and ceasing operations on select manufacturing lines at other locations, anticipated to be substantially completed in 2024. This restructuring initiative is expected to incur pre-tax charges totaling $410 million to $460 million. These charges are composed of severance costs, asset impairments (notably $165-$175 million for the Pittsburg site's operating lease assets and property, plant, and equipment), and contract termination costs. The company anticipates future cash payments of $90 million to $120 million related to these charges, primarily for severance and contract termination obligations. Investors should monitor the impact of these restructuring efforts on future operational efficiency and financial performance.

Corteva, Inc. (CTVA) filed an 8-K on October 27, 2023, to furnish a press release announcing preliminary results for the quarter ended September 30, 2023, and updated full-year 2023 guidance. While specific financial figures are not detailed within the 8-K itself, these preliminary results and guidance updates are critical for investors to assess the company's recent performance and future outlook. The furnished press release (Exhibit 99.1) will contain the detailed sales and earnings figures, along with any revisions to previously provided financial expectations for the full year. Investors should pay close attention to the details in the accompanying press release to understand the drivers behind the quarter's performance and the reasoning for any changes in the full-year guidance. This includes analyzing segment-specific sales, profitability trends, and any commentary on market conditions that may have influenced these preliminary results. The information furnished in this report, while not deemed "filed" in the traditional sense, serves as an important communication channel for the company to provide timely updates to the market.

Corteva, Inc. reported net sales of $6.045 billion for the second quarter of 2023, a 3% decrease compared to the prior year, primarily driven by a 13% volume decline, partially offset by a 9% increase in price. The six-month period showed a 1% increase in net sales to $10.929 billion, with an 11% price increase offsetting a 9% volume decline. Net income for the quarter was $714 million ($1.00 per diluted share), down from $969 million ($1.33 per diluted share) in the same period last year. The company completed significant acquisitions of Stoller and Symborg in March 2023, integrating biological and microbiological technologies into its crop protection portfolio. Despite overall sales challenges, the company highlighted strong price execution and ongoing cost and productivity initiatives, while also managing increased interest expenses and investing in R&D.

Corteva, Inc. announced its second quarter 2023 financial results on August 3, 2023. The company reported its consolidated financial performance for the quarter ended June 30, 2023. Investors should refer to the press release (Exhibit 99.1) and financial statement schedules (Exhibit 99.2) furnished with this 8-K filing for detailed insights into the company's operational and financial condition during the period. This filing primarily serves to furnish the aforementioned financial information and does not constitute a formal filing under Section 18 of the Securities Exchange Act of 1934. Therefore, the liabilities associated with such a filing do not apply. The information presented is intended to be informative for stakeholders regarding Corteva's recent performance.

Corteva, Inc. (CTVA) announced through its subsidiary, EIDP, Inc., the successful issuance of $1.2 billion in aggregate principal amount of senior notes on May 15, 2023. This offering consisted of $600 million of 4.500% Senior Notes due 2026 and $600 million of 4.800% Senior Notes due 2033. The notes were issued under an existing indenture, supplemented by a second supplemental indenture, and were registered under the Securities Act of 1933. This debt issuance provides Corteva with additional capital, which can be utilized for various corporate purposes, potentially including general corporate operations, strategic investments, or refinancing existing debt. Investors should note the specific coupon rates and maturity dates to assess the company's cost of debt and its long-term financial obligations. The participation of major underwriters like Goldman Sachs, BofA Securities, and SMBC Nikko Securities indicates a standard and well-executed capital markets transaction.

Corteva, Inc. reported a net sales increase of 6% to $4.88 billion for the first quarter of 2023, driven by a 14% price increase, partially offset by a 4% volume decrease and a 5% unfavorable currency impact. Net income increased to $595 million, or $0.83 per diluted share, compared to $564 million, or $0.78 per diluted share, in the prior year's quarter. The company completed significant acquisitions of Stoller Group, Inc. and Quorum Vital Investment, S.L. (Symborg) for a combined $1.6 billion, strengthening its biologicals and microbiological technologies portfolio. Corteva also updated its full-year 2023 guidance, raising its net sales and Operating EBITDA expectations to reflect the impact of these acquisitions.

Corteva, Inc. (CTVA) filed an 8-K on May 3, 2023, to announce its first-quarter 2023 financial results. The filing indicates that the company's financial performance for the quarter ended March 31, 2023, was detailed in an accompanying press release and financial statement schedules, furnished as exhibits. Investors should note that this information is being furnished and not formally filed under Section 18 of the Exchange Act, meaning it does not carry the same liability. However, it provides a timely update on the company's operational and financial condition as of that period, offering insights into sales, profitability, and other key metrics relevant to understanding Corteva's recent performance in the agricultural sector.

Corteva, Inc. (CTVA) filed an 8-K on April 26, 2023, detailing the results of its Annual Meeting of Stockholders held on April 21, 2023. The primary purpose of the filing was to report the outcomes of shareholder votes on key corporate matters, including the election of directors, an advisory vote on executive compensation, and the ratification of the company's independent auditor. The meeting saw strong participation, with over 87% of outstanding shares represented. Key outcomes include the overwhelmingly approved election of all 13 director nominees, indicating shareholder confidence in the current board's leadership. Additionally, shareholders provided an advisory approval for the compensation of named executive officers. The appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm for 2023 was also ratified by a significant majority, reinforcing the company's commitment to financial transparency and independent oversight.

Corteva, Inc. reported strong performance in 2022 with an 11% increase in net sales, reaching $17.5 billion, driven by robust price execution and volume growth across all regions. The company's Seed segment saw a 7% sales increase, primarily due to price hikes, while the Crop Protection segment experienced a significant 17% sales jump, fueled by both price increases and volume growth, particularly from new product introductions. Despite facing headwinds from unfavorable currency impacts and rising input costs, Corteva demonstrated effective cost management and productivity actions, leading to an improvement in Operating EBITDA by 25% to $3.2 billion. The company also returned approximately $1.4 billion to shareholders through share repurchases and dividends. Looking ahead to 2023, Corteva anticipates continued growth, projecting net sales between $18.1 billion and $18.4 billion and Operating EBITDA between $3.4 billion and $3.6 billion, signaling confidence in its strategic priorities and market position.

Corteva, Inc. (CTVA) filed an 8-K on February 1, 2023, to announce its financial results for the fourth quarter and full year ended December 31, 2022. The filing includes a press release and financial statement schedules, which provide details on the company's performance. While this report furnishes the information and is not deemed "filed" for liability purposes, it serves as a key communication to investors regarding the company's operational and financial standing. Investors should note that this 8-K primarily serves to announce these results, and the detailed forward-looking statements and risk factors are further elaborated in the company's Form 10-K and subsequent filings. The company emphasizes that actual results may differ materially from projections due to various risks and uncertainties, including those related to product development, regulatory approvals, market conditions, input cost volatility, and geopolitical events.

Corteva, Inc. (CTVA) filed an 8-K on December 21, 2022, to report on an amendment and restatement of its bylaws, effective December 15, 2022. The primary driver for these changes is to comply with new SEC regulations, specifically Rule 14a-19, which mandates the use of universal proxy cards in director election contests. The updated bylaws introduce specific procedural requirements for stockholders seeking to nominate directors, including stipulations on proxy solicitation and the use of proxy card colors. These amendments are designed to align Corteva's corporate governance with current regulatory standards and streamline certain administrative processes. While the changes are largely technical and driven by compliance, investors should note the increased burden on stockholders initiating proxy contests related to director nominations. Additionally, a procedural change was made to remove the requirement for the company to maintain a detailed list of stockholders for inspection at meetings, aligning with updated Delaware corporate law.

Corteva, Inc. (CTVA) reported a strong increase in net sales for the third quarter and the first nine months of 2022, driven by significant price increases and volume growth across both its Seed and Crop Protection segments. Despite these top-line gains, the company experienced a net loss in the third quarter, primarily due to substantial restructuring and asset-related charges, including costs associated with exiting Russia. For the nine-month period, net income was lower year-over-year, also impacted by these charges. The company affirmed its full-year net sales outlook and increased its Operating EBITDA guidance, signaling confidence in its operational performance and market position despite macroeconomic headwinds and inflationary pressures.

Corteva, Inc. (CTVA) filed an 8-K on November 3, 2022, primarily to furnish its earnings press release and financial statement schedules for the quarter ended September 30, 2022. While this filing doesn't introduce new material events, it provides investors with the company's latest financial performance data. The key takeaway for investors is the direct access to the company's reported results and commentary, which are crucial for understanding operational performance, profitability, and any forward-looking statements or guidance. Investors should refer to the furnished Exhibits 99.1 (Press Release) and 99.2 (Financial Statement Schedules) for detailed insights into Corteva's financial condition and results of operations for the third quarter of 2022. This includes metrics such as revenue, earnings per share, and any management discussion on factors influencing these results, such as market conditions, product demand, and strategic initiatives. It's important to note that the information furnished is not considered "filed" for certain liability purposes under the Exchange Act.

Corteva, Inc. reported strong performance for the second quarter and first half of 2022, with net sales increasing by 11% year-over-year for both periods. This growth was driven by a robust increase in pricing (9%) and volume (4% and 5% respectively), indicating effective execution of its "price for value" strategy and successful new product introductions. Despite facing headwinds from unfavorable currency impacts, particularly from the Turkish Lira and Euro, and rising input costs, the company demonstrated resilience through ongoing cost and productivity initiatives. The company's Seed segment saw a 4% increase in net sales for Q2, driven by strong pricing, while the Crop Protection segment experienced significant growth of 25% due to higher volumes and pricing. This strong operational performance translated into improved profitability, with Segment Operating EBITDA increasing significantly in both segments, especially in Crop Protection. Corteva also reiterated its positive outlook for the full year 2022, increasing its net sales and Operating EBITDA guidance, reflecting confidence in its strategic direction and market position.

Corteva, Inc. (CTVA) filed an 8-K on August 4, 2022, primarily to furnish its second-quarter 2022 earnings press release and financial statement schedules. The filing also detailed significant restructuring actions and associated charges. The company announced its commitment to restructuring initiatives, including its withdrawal from Russia, which resulted in $56 million in pre-tax restructuring and other charges for the three and six months ended June 30, 2022. Additionally, Corteva indicated that future restructuring actions, excluding the Russia exit, are expected to incur total pre-tax charges ranging from $295 million to $350 million, with estimated cash payments of $180 million to $210 million, anticipated to be substantially completed by 2023. These restructuring efforts are part of a strategic shift to a global business unit model aimed at enhancing customer experience and driving growth. Investors should note the forward-looking nature of these charges and the inherent risks and uncertainties detailed in the filing and referenced documents. The company also flagged potential additional pre-tax charges of up to $30 million related to the Russia exit, primarily concerning government receivables and inventory.

Corteva, Inc. (CTVA) filed an 8-K on May 4, 2022, detailing the results of its Annual Meeting of Stockholders held on April 29, 2022. The filing indicates strong shareholder participation, with over 86% of outstanding shares represented. All key proposals presented to shareholders received substantial approval, reflecting general confidence in the company's direction and governance. Key outcomes include the election of all 13 director nominees, the advisory approval of executive compensation, and the ratification of PricewaterhouseCoopers LLP as the independent registered public accounting firm for 2022. The high voter turnout and overwhelming support for the directors and accounting firm suggest a stable and well-aligned shareholder base.

Corteva, Inc. reported a solid first quarter for 2022, with net sales increasing by 10% year-over-year to $4.6 billion. This growth was primarily driven by a 9% increase in price and a 7% rise in volume, reflecting strong demand and successful pricing strategies, although partially offset by a 6% unfavorable currency impact. The company's operating EBITDA also saw a significant improvement, up 15% to $1.04 billion, demonstrating effective cost management and strong sales execution across all regions, despite inflationary pressures on input and logistics costs. The company continues to return capital to shareholders, repurchasing approximately $335 million in common stock and paying dividends in the first quarter. Corteva is affirming its full-year 2022 outlook for net sales and Operating EBITDA, indicating confidence in continued performance. However, investors should note the ongoing global economic uncertainties, including the conflict in Ukraine and associated sanctions, which have led Corteva to announce its withdrawal from Russia, expecting related charges. The company also faces ongoing litigation and environmental matters, which, while managed, represent potential contingent liabilities.

Corteva, Inc. announced its first-quarter 2022 financial results on May 4, 2022. While the 8-K filing itself is brief and primarily serves to furnish the press release and financial statements as exhibits, the disclosed information pertains to the company's performance during the quarter ended March 31, 2022. Investors should refer to the furnished press release (Exhibit 99.1) and financial statement schedules (Exhibit 99.2) for the detailed financial performance, operational highlights, and forward-looking statements. These documents will contain the specific revenue, earnings, and segment performance metrics that are crucial for evaluating Corteva's current financial health and strategic direction. The furnished materials provide the primary source of detailed financial information. The 8-K filing ensures these documents are publicly accessible and satisfy disclosure requirements, but the substance of the results and management's commentary are within the accompanying exhibits. Investors are advised to review these exhibits carefully for a comprehensive understanding of Corteva's first-quarter 2022 performance.

Corteva, Inc. (CTVA) reported strong performance in its 2021 fiscal year, with net sales increasing by 10% to $15.7 billion, driven by a 5% volume increase and a 4% price increase. This growth was supported by the successful penetration of new products and the company's "price for value" strategy, which helped offset rising raw material and logistics costs. Operating EBITDA also saw a significant increase, reaching $2.6 billion, up from $2.1 billion in the prior year, reflecting robust price execution and volume gains across all regions and segments. The company continued to return capital to shareholders, with approximately $1.3 billion deployed through share repurchases and dividends in 2021. Corteva also announced an increase in its common stock dividend and a new $1.5 billion share repurchase program, signaling confidence in its ongoing financial strength and commitment to shareholder returns. The company's strategic priorities focus on leveraging its innovation pipeline, driving margin expansion through operational excellence, generating strong cash flow, and deploying capital in a balanced way for growth and shareholder returns.

Corteva, Inc. (CTVA) announced the retirement of Rajan Gajaria, Executive Vice President of Business Platforms, effective February 18, 2022. Mr. Gajaria's departure represents a leadership change within a key business segment. Additionally, the company has designated its Indianapolis, Indiana offices as its global headquarters. This move could signal a strategic realignment or a strengthening of its presence in Indianapolis. Investors should note these changes as they may impact business operations and strategic direction. While no immediate financial impact is disclosed, leadership transitions and headquarters changes are significant events that warrant monitoring for their potential effects on future performance and investor relations. The company has also reiterated its standard forward-looking statements disclosure.

Corteva, Inc. (CTVA) filed an 8-K on February 2, 2022, to report its financial results for the fourth quarter and full year ended December 31, 2021. The filing primarily announces the release of the company's earnings press release and financial statement schedules, which are furnished as exhibits. This 8-K serves as notification to investors that these results are now publicly available. Investors should refer to the furnished Exhibits 99.1 and 99.2 for the detailed financial performance, including key metrics like revenue, earnings per share, and segment performance for the periods reported. While this 8-K itself does not contain the specific financial figures, it is the official channel through which Corteva disseminates this crucial information. The filing also includes a standard cautionary statement regarding forward-looking statements, highlighting potential risks and uncertainties that could affect future results.

Corteva, Inc. (CTVA) reported a significant turnaround in its third quarter of 2021 compared to the same period in 2020, demonstrating strong top-line growth and improved profitability. Net sales surged by 27% year-over-year, driven by a robust 17% increase in volume and a 7% price increase, reflecting successful new technology adoption and effective pricing strategies across its Seed and Crop Protection segments. The company's Operating EBITDA also saw substantial improvement, turning positive and indicating effective cost management amidst inflationary pressures. For the nine-month period, Corteva continued its positive momentum with an 11% increase in net sales, driven by solid volume and price gains. The company successfully navigated cost headwinds, such as higher input and logistics expenses, through ongoing productivity initiatives and favorable currency impacts. Corteva also reaffirmed its full-year 2021 outlook for net sales and operating earnings per share, signaling confidence in its continued performance. The company also returned significant capital to shareholders through share repurchases and dividends.

Corteva, Inc. (CTVA) filed an 8-K on November 2, 2021, to report its third-quarter 2021 financial results, which were announced on November 3, 2021. While the 8-K itself primarily serves as a cover for the furnished press release and financial statements, these documents contain the critical details for investors regarding the company's performance during the period ending September 30, 2021. Investors should review the provided exhibits (99.1 and 99.2) for in-depth financial and operational insights.

Corteva, Inc. has announced a significant leadership transition, appointing Charles Victor ("Chuck") Magro as its new Chief Executive Officer, effective November 1, 2021. Mr. Magro succeeds James C. Collins, Jr., who is retiring. Magro brings substantial experience to Corteva, having previously served as CEO of Nutrien Ltd. and its predecessor, Agrium Inc. This leadership change is a critical event for investors, signaling a new direction and strategic focus under experienced leadership. His compensation package includes a base salary of $1.3 million, a significant incentive opportunity, and long-term incentive awards, reflecting the company's investment in its new leader. The appointment comes with a substantial one-time payment of $18.7 million to Nutrien to coordinate Mr. Magro's existing restrictive covenants. This outlay, while significant, aims to ensure a smooth transition and leverage Magro's expertise without immediate encumbrances. Investors will be keen to monitor how Magro's leadership impacts Corteva's strategic initiatives, operational performance, and shareholder value moving forward, particularly given his proven track record in the agricultural sector.

Corteva, Inc. reported strong financial results for the second quarter and first half of 2021, demonstrating robust top-line growth and improved profitability. Net sales increased by 8% in the second quarter and 7% for the first half, driven by volume increases across both the Seed and Crop Protection segments. This growth was supported by a 5% volume increase in Q2 and 4% in H1, along with favorable currency impacts and modest price increases. The company also saw a significant improvement in profitability, with income from continuing operations after income taxes rising to $1,018 million in Q2 2021 and $1,631 million in H1 2021, compared to $766 million and $1,047 million respectively in the prior year periods. This profitability enhancement was driven by strong price execution, volume gains, and effective cost and productivity actions, which helped offset increased input costs and logistics challenges. Corteva also continues to actively manage its capital structure and return value to shareholders. The company announced a new $1.5 billion share repurchase program and increased its quarterly dividend. Despite facing inflationary pressures and supply chain constraints, Corteva raised its full-year 2021 outlook, anticipating a 7-8% increase in net sales and significant growth in Operating EBITDA and Operating Earnings Per Share. The company remains focused on innovation and operational efficiency to drive future growth and shareholder returns.